-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Vor Biopharma Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2020 to 31 Mar 2025.
- Vor Biopharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $606,000, a 731% decline year-over-year.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $53,392,000, a 1717% increase from 2023.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,938,000, a 97% decline from 2022.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $117,140,000, a 50% decline from 2021.